Department of Medicine, Division of Infectious Diseases, University of Southern California Keck School of Medicine, Los Angeles, California, United States of America.
PLoS One. 2012;7(8):e42624. doi: 10.1371/journal.pone.0042624. Epub 2012 Aug 30.
Circulating levels of microbial products are increased in HIV infection, and provoke endothelial dysfunction in other disease settings.
METHODOLOGY/PRINCIPAL FINDINGS: We examined data from a cross-sectional single site study at Indiana University (Indiana, N = 85) and a 24- week multicenter prospective study of antiretroviral therapy (ART) initiation (ACTG 5152s, N = 75). Brachial artery flow-mediated dilation (FMD) was measured by ultrasound. Plasma lipopolysaccharide (LPS) and soluble CD14 (sCD14) levels were measured from stored specimens and correlated with FMD values using Pearson correlations. The Indiana subjects were 63% male with a mean age of 39 years and a median CD4 count of 406 cells/mm(3) (388 not on ART, 464 on ART). The 5152s subjects were 92% were male with a mean age of 35 years and a median CD4 count of 251 cells/mm(3) at entry which increased to 396 cells/mm(3) on ART. When analyzing the two cohorts individually or in combination neither sCD14 nor LPS correlated significantly with FMD. In a pre-specified subgroup analysis of the Indiana subjects receiving ART (N = 46, mean ART duration 40 months) LPS was inversely correlated with FMD (r = -0.33, p = 0.02), but not sCD14 (r = -0.01, p = 0.9). Multivariate analysis confirmed LPS as an independent predictor of FMD in this subgroup (p = 0.02).
CONCLUSIONS/SIGNIFICANCE: In HIV-infected individuals on prolonged ART, higher LPS levels are associated with worse endothelial function but not in untreated subjects or at 24 weeks after ART initiation. Persistent microbial translocation may contribute to arterial dysfunction and the increased cardiovascular disease risk observed in individuals on long-term ART.
在 HIV 感染中,循环微生物产物水平升高,并在其他疾病环境中引发内皮功能障碍。
方法/主要发现:我们检查了印第安纳大学(印第安纳州)的一项横断面单站点研究的数据(印第安纳组,n=85)和一项抗逆转录病毒治疗(ART)启动的 24 周多中心前瞻性研究(ACTG 5152s,n=75)的数据。肱动脉血流介导的扩张(FMD)通过超声测量。从储存的标本中测量血浆脂多糖(LPS)和可溶性 CD14(sCD14)水平,并使用 Pearson 相关系数将其与 FMD 值相关联。印第安纳组受试者 63%为男性,平均年龄为 39 岁,中位 CD4 计数为 406 个细胞/mm³(388 个未接受 ART,464 个接受 ART)。5152s 组受试者 92%为男性,平均年龄为 35 岁,入组时的中位 CD4 计数为 251 个细胞/mm³,接受 ART 后增加到 396 个细胞/mm³。当单独或联合分析两个队列时,sCD14 和 LPS 均与 FMD 无显著相关性。在印第安纳组接受 ART 的预先指定亚组分析中(n=46,平均 ART 持续时间为 40 个月),LPS 与 FMD 呈负相关(r=-0.33,p=0.02),但与 sCD14 无关(r=-0.01,p=0.9)。多变量分析证实 LPS 是该亚组 FMD 的独立预测因子(p=0.02)。
结论/意义:在接受长期 ART 的 HIV 感染个体中,较高的 LPS 水平与内皮功能障碍相关,但在未治疗的个体或 ART 启动后 24 周时并非如此。持续的微生物易位可能导致动脉功能障碍,并导致长期接受 ART 的个体心血管疾病风险增加。